AACR to Unveil Cancer Progress Report 2024 on September 18
Registration for the in-person briefing and virtual live stream is open
WHAT
The American Association for Cancer Research (AACR) will host a congressional briefing to unveil the AACR Cancer Progress Report 2024 at the National Press Club in Washington, D.C. There will also be a virtual live stream of the event.
The 14th edition of the AACR Cancer Progress Report provides the latest statistics on cancer incidence, mortality, and survivorship. It also includes a spotlight on childhood and adolescent and young adult cancers, information about modifiable cancer risk factors such as alcohol use, and research on the economic impact of this disease. The report features a number of personal stories from patients who have benefited from innovative anticancer therapeutics, highlighting the real-world impact of medical research. A closing call to action outlines steps Congress must take to ensure that the United States maintains its momentum against cancer for the benefit of all patients.
WHEN
Wednesday, September 18, 2024
11:30 a.m. ET
WHERE
National Press Club
529 14th St NW, 13th Floor
Washington, D.C. 20045
To register to attend the briefing in person, please fill out this form. To register to view the event live stream, please fill out this form.
WHO
The briefing will include remarks from and a panel discussion featuring cancer experts and survivors.
Welcoming Remarks
- Margaret Foti, PhD, MD (hc), AACR Chief Executive Officer
Keynote Address
- Patricia M. LoRusso, DO, PhD (hc), FAACR, AACR President; Yale Cancer Center
Panel
- John L. Cleveland, PhD, Member, AACR Cancer Progress Report 2024 Steering Committee; Moffitt Cancer Center, University of South Florida Morsani College of Medicine
- Michael Pignone, MD, MPH, Member, AACR Cancer Progress Report 2024 Steering Committee; Duke Cancer Institute
- Humberto M. Guiot, MD, Vicki W. Jones, Lourdes Monje, and Emily and Michael Methner, cancer survivors and patient advocates featured in the AACR Cancer Progress Report 2024
The event will conclude with a Q&A session.